Answers are grounded in this paper and cite their sources.
Background Hospital-acquired wound infections due to multi-drug resistant (MDR) Gram-negative pathogens, remain one of the leading causes of clinical complications and mortality. Understanding their resistance patterns and genetic insights is an essential step at reducing this burden in hospital settings. This study determines the resistance patterns of MDR organisms and molecularly characterized extended spectrum beta-lactamase (ESBL)-producers and carbapenem-resistant (CR) E. coli and K. pneumoniae isolated from wound samples from a tertiary hospital in Ghana. Methods We analyzed 200 Gram-negative clinical isolates. Species were identified by microbiological biochemical test reactions and confirmed with MALDI-TOF. Antimicrobial susceptibility was determined by Kirby-Bauer disc diffusion method. Isolates with ≥ 5 mm increase in zone of inhibition for cefotaxime/ceftriaxone alone and/or in combination with clavulanate, were considered ESBL-producers whilst those resistant to meropenem were considered carbapenem resistant (CR). Nine ESBL-producers (E. coli, n = 5; K. pneumoniae, n = 4) and 2 CR (E. coli n = 1; K. pneumoniae n = 1) were whole genome sequenced on GridION platform (Oxford Nanopore Technologies). Results Clinical resistance to cefuroxime (147/200, 74%), ampicillin (137/200, 69%), gentamicin (126/200, 63%), ceftriaxone (120/200, 60%) and ciprofloxacin (120/200, 60%) was common. However, the majority (178/200, 89%) of the isolates were susceptible to meropenem. In total for all species, the rates of MDR, ESBL production and carbapenem-resistance were 74% (148/200), 53% (106/200) and 10.5% (21/200) respectively. The blaCTX-M-15 was the most predominant ESBL gene (11/11, 100%) and was found to co-exist with other beta-lactamases including blaOXA-181 and blaNDM-1. Conclusions The concerning frequency of MDR and ESBL-production among clinical strains calls for strict adherence to antimicrobial stewardship programs. To the best of our knowledge, we report for the first time the emergence of CTX-M-15, NDM-1-producing K. pneumoniae in Ghana. Continued surveillance, coupled with intensive infection prevention and control (IPCs) strategies are essential to control the further spread of these strains in Ghana.
No takes yet. Share an insight, caveat, or question.
Ashley-Agbedor et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: